EAU 2013 - Programme Book - YouMed

Saturday, 16 March - EAU Programme
Abstract Session
08.30 - 10.00 Non-surgical treatment of advanced urothelial cancer
Blue Hall 1-2 - Level N1
Poster Session 7
Chairs: J. Bellmunt, Barcelona (ES)
P. Gontero, Turin (IT)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion. Extended presentations (*) are 4 minutes in length, followed
by 2 minutes for discussion.
* 74 Interval between cystectomy and start of adjuvant chemotherapy is an independent prognostic factor for
patients with locally advanced or lymph node positive carcinoma of the urinary bladder
C.H. Ohlmann, J. Kamradt, B. Burgard, M. Saar, I. Azone, S. Siemer, M. Stöckle, J. Lehmann (Homburg, Kiel,
Germany)
75 Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients
R.H. Thompson, S.A. Boorjian, S. Kim, J.C. Cheville, P. Thapa, R. Tarrel, I. Frank (Rochester, United States of
America)
76 Risk factors for intravesical tumor recurrence in muscle-invasive bladder cancer patients treated with
selective bladder-sparing approaches
F. Koga, Y. Fujii, J-I. Ishioka, Y. Matsuoka, N. Numao, K. Saito, H. Masuda, S. Kawakami, K. Kihara (Tokyo,
Japan)
77 Predicting responses to neoadjuvant chemotherapy for muscle invasive bladder cancers for prospective
study
Y. Kato, H. Zembutsu, R. Takata, K. Iwasaki, W. Obara, Y. Nakamura, T. Fujioka (Morioka, Sapporo, Japan;
Chicago, United States of America)
78 Impact of renal function on eligibility for chemotherapy and survival in patients who underwent radical
nephroureterectomy
E.N. Xylinas, M. Rink, L.A. Kluth, V. Margulis, R.K. Lee, E. Comploj, G. Novara, J.D. Raman, Y. Lotan,
A. Weizer, M. Roupret, A. Pycha, D. Scherr, C. Seitz, V. Ficarra, Q-D. Trinh, P.I. Karakiewicz, F. Montorsi,
M. Zerbib, S.F. Shariat (New York, Dallas, Hershey, Ann Arbor, United States of America; Bolzano, Padua,
Milan, Italy; Paris, France; Vienna, Austria; Montreal, Canada)
79 Sequential chemotherapy with gemcitabine plus carboplatin followed by additional docetaxel for aged
patients with advanced bladder cancer
T. Yoneyama, Y. Suzuki, N. Sugiyama, H. Yamamoto, A. Okamoto, Y. Tobisawa, T. Yoneyama, A. Imai,
K. Mori, S. Hatakeyama, Y. Hashimoto, T. Koie, C. Ohyama (Hirosaki, Japan)
* 80 Adjuvant radiotherapy with or without chemotherapy for advanced upper tract transitional cell carcinoma
S. Park, M. Shim, D. Yoo, C. Song, B. Hong, J.H. Hong, C.S. Kim, H. Ahn (Seoul, South Korea)
81 Peri-operative chemotherapy or surveillance in upper tract urothelial cancer (POUT - CRUK/11/027) - a
randomised controlled trial to define standard post-operative management
A. Birtle, R. Lewis, J. Chester, J. Donovan, M. Johnson, R. Jones, R. Kockelbergh, T. Powles, R. Bryan, J. Catto,
E. Jones, E. Hall (Preston, Surrey, Cardiff, Bristol, Newcastle, Glasgow, Leicester, London, Birmingham,
Sheffield, United Kingdom)
EAU Milan 2013
89
Saturday